BENLYSTA

Prescription medicines

BENLYSTA

Product information:

BENLYSTA product monograph

Health-care professional information:

April 4^th, 2019 – Important new safety information regarding BENLYSTA (belimumab)

April 25^th, 2014 – Important new safety information regarding BENLYSTA (belimumab)

May 3, 2012- Important safety information regarding the association of BENLYSTA (belimumab) with hypersensitivity and infusion reactions.

Patient information:

April 25^th, 2014 – Important new safety information for patients currently receiving BENLYSTA (belimumab)

May 8, 2012- Important information for patients regarding the association of BENLYSTA (belimumab) with hypersensitivity and infusion reactions.

 

Trademarks are owned by or licensed to the GSK group of companies.